Nestle, Zydus Wellness hit 6 month lows after FSSAI notices

Nestle India and Zydus Wellness came under sharp pressure on Thursday after the Food Safety and Standards Authority of India (FSSAI) issued notices to both companies over allegedly misleading claims on certain ***** India stock fell nearly 3.7 per cent to hit a six-month low of Rs 1,187.10. At the time of writing, it was trading around Rs 1,187, down about 3 per cent. Zydus Wellness dropped over 3 per cent, slipping below its six-month low to around Rs ***** regulator has questioned Nestle’s claims on two infant nutrition products—Lactogen Pro 1 and Nan Excella Pro Stage 1. FSSAI has sought scientific proof for statements such as whey protein being “easy to digest” and “5 HMOs help support the normal immune system.” The regulator has also asked Nestle to explain why action should not be initiated under the FSS ***** the case of Zydus Wellness’ Complan, FSSAI flagged claims including “2X Faster Growth,” “Supports Concentration and Memory,” and “Pro Immunity+ 34 Vital Nutrients,” along with the advertisement line “growth comes in 4 flavors.” The company has been directed to provide scientific justification.